MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 80 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,400 | +6300.0% | 17,777 | -91.6% | 0.00% | – |
| Q1 2023 | $100 | -16.7% | 211,927 | -11.5% | 0.00% | – |
| Q4 2022 | $120 | -99.6% | 239,401 | +714.0% | 0.00% | – |
| Q1 2021 | $31,000 | -94.8% | 29,409 | -93.3% | 0.00% | – |
| Q4 2020 | $597,000 | +1513.5% | 438,932 | +803.0% | 0.00% | – |
| Q3 2020 | $37,000 | -88.0% | 48,608 | -87.8% | 0.00% | – |
| Q2 2020 | $309,000 | -46.3% | 399,770 | -58.3% | 0.00% | -100.0% |
| Q1 2020 | $575,000 | +168.7% | 958,507 | +916.6% | 0.00% | – |
| Q4 2019 | $214,000 | -12.3% | 94,282 | -75.7% | 0.00% | – |
| Q3 2019 | $244,000 | -50.1% | 388,530 | -32.0% | 0.00% | -100.0% |
| Q2 2019 | $489,000 | -53.7% | 571,323 | -41.0% | 0.00% | -50.0% |
| Q1 2019 | $1,056,000 | +1430.4% | 968,908 | +1195.1% | 0.00% | – |
| Q3 2018 | $69,000 | -28.9% | 74,816 | -66.5% | 0.00% | – |
| Q2 2018 | $97,000 | +12.8% | 223,298 | +339.9% | 0.00% | – |
| Q2 2017 | $86,000 | -89.9% | 50,766 | -83.5% | 0.00% | -100.0% |
| Q1 2017 | $854,000 | – | 308,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,923,000 | $509,990 | 0.12% |
| Arkadios Wealth Advisors | 1,399,000 | $181,870 | 0.02% |
| NEVILLE RODIE & SHAW INC | 1,157,332 | $150 | 0.01% |
| Platform Technology Partners | 162,410 | $21,113 | 0.01% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $101 | 0.01% |
| Main Street Financial Solutions, LLC | 400,826 | $52,107 | 0.01% |
| National Wealth Management Group, LLC | 42,750 | $5,558 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 400,000 | $52,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 754,732 | $98,115 | 0.00% |
| HYMAN CHARLES D | 79,800 | $10,000 | 0.00% |